Quarterly Report on Life Sciences Venture Activity

This report serves as a quarterly analysis of life sciences venture capital (VC) trends, focusing on deal activity, valuations, and exit performance as of September 30, 2024. It outlines that life sciences VC deal activity has rebounded significantly, with a year-to-date total of $25.7 billion raised across 1,232 deals, indicating a potential recovery from previous declines. The report details that median deal sizes have increased, particularly in early-stage investments, with the median early-stage deal size reaching $10.6 million. It also notes a growing trend in larger check sizes, with 84.3% of the total deal value in 2024 attributed to deals exceeding $25 million. However, exit activity has been sluggish, with a total of $34 billion generated across 83 exits, which is below historical averages. The report highlights that while exit values have increased, the number of deals has decreased, reflecting a challenging environment for life sciences exits amidst tightening monetary policies.